PHD2: from hypoxia regulation to disease progression
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085284/
Apr 11, 2016 · in this regard, phd2 hydroxylates pde4d, targeting this protein for degradation by the ubiquitin-proteasome pathway and leading to an increase in camp levels in the cardiomyocytes. 61 additionally, phd2 and phd3 were found to hydroxylate the thyroid hormone receptor-α (tr-α), leading to the decrease of its binding to the nuclear receptor … Author: Ana M Meneses, Ben Wielockx Publish Year: 2016
Author: Ana M Meneses, Ben Wielockx
Publish Year: 2016
DA: 77 PA: 95 MOZ Rank: 67